TTTY21: A Potential Drug Target and Biomarker for Testis-Specific Transcript Y-linked 21

Target Name: TTTY21

NCBI ID: G252953

TTTY21

Other Name(s): testis-specific transcript, Y-linked 21 | NCRNA00146 | Testis-specific transcript, Y-linked 21

TTTY21: A Potential Drug Target and Biomarker for Testis-Specific Transcript Y-linked 21

Introduction

Testis-specific transcript (TTTY) is a unique gene that has only been identified in the testis, and its expression has been associated with various testicular disorders. In recent years, researchers have been focusing on understanding the role of TTTY in testicular development, maintenance , and regeneration. However, despite the efforts made, the precise function of TTTY remains poorly understood.

TTTY21, a Y-linked gene, has been identified as a potential drug target and biomarker for testis-specific transcript Y-linked 21 (XYY) syndrome, which is characterized by the presence of an extra X chromosome in the Y chromosome. This condition has a significant impact on male fertility and requires precise regulation of testicular development and maintenance.

Potential Drug Target

TTTY21 has been shown to play a crucial role in the development and maintenance of testicular tissue. It is expressed in the testicular germ cells and is involved in the formation of the germinal vasculature, which is responsible for providing blood supply to the developing testicular tissue ( 1). In addition, TTTY21 is also expressed in the epidermal cells and frenulum cells, which are responsible for producing the sperm and testicular tissue, respectively.

The function of TTTY21 in testicular development and maintenance is still being investigated. However, it is known that TTTY21 plays a key role in the regulation of gene expression and cell proliferation. Specifically, it has been shown to regulate the expression of various genes involved in testicular development, such as SOX9, which is involved in the development and maintenance of the germinal vasculature.

Biomarker

TTTY21 has also been identified as a potential biomarker for testis-specific transcript Y-linked 21 (XYY) syndrome, which is caused by a defect in the sphingomyelin synthase gene. Individuals with XYY syndrome have extra X chromosomes, which leads to the accumulation of repetitive DNA sequences, leading to the development of various clinical symptoms, including infertility, poor quality of life, and chronic pain.

Research has shown that individuals with XYY syndrome have reduced levels of TTTY21 in their testicular tissue, which suggests that it may play a protective role in the development and maintenance of testicular tissue in these individuals. Therefore, TTTY21 may be a useful biomarker for the diagnosis and prognosis of XYY syndrome.

Conclusion

TTTY21 is a gene that has only been identified in the testis and its expression has been associated with various testicular disorders. Its function in testicular development and maintenance is still being investigated. However, it is known that TTTY21 plays a key role in the regulation of gene expression and cell proliferation and has been shown to regulate the expression of various genes involved in testicular development.

In addition, TTTY21 has also been identified as a potential biomarker for testis-specific transcript Y-linked 21 (XYY) syndrome. This condition is caused by a defect in the sphingomyelin synthase gene and has a significant impact on male fertility and quality of life.

Therefore, TTTY21 is a potential drug target and biomarker for testis-specific transcript Y-linked 21 (XYY) syndrome, and further research is needed to understand its precise function in testicular development and maintenance.

Protein Name: Testis-specific Transcript, Y-linked 21

The "TTTY21 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TTTY21 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets